Potential new drug targets against hormone-dependent breast cancer identified.
D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D020847:Estrogen Receptor Modulators / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D009362:Neoplasm Metastasis; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D009589:Nitrogen Oxides / Q000378:metabolism; D043823:Taxoids / Q000627:therapeutic use; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
D047072:Aromatase Inhibitors; D020847:Estrogen Receptor Modulators; D009589:Nitrogen Oxides; D043823:Taxoids; D016159:Tumor Suppressor Protein p53; C039900:nitroxyl; C479543:tesetaxel